 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 Common temporary side effects noted in patients who received the blood substitute included skin discoloration interpreted as jaundice, elevated blood pressure, and increased levels of the enzymes troponin and lipase.
The study, published in the June issue of the Journal of Trauma: Injury, Infection, and Critical Care, was funded by the Biopure Corporation, which makes HBOC-201.
The need to develop an alternative to red blood cells is being driven by a predicted shortfall of more than four million units of blood worldwide, according to background information in the study.
Text Continues Below

More information
America's Blood Centers has more about blood transfusions.
Page: << Prev | 1 | 2
-- Robert Preidt
|